| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communications |
1 From the Institute of Social and Preventive Medicine, University of Zurich; the Geriatric University Clinic Basel, Switzerland; and Clinical Research Biometrics, F Hoffmann-La Roche Ltd, Basel, Switzerland.
Background: Low serum cholesterol has been associated with an increased risk of cancer mortality in various studies, which has led to uncertainty regarding the benefit of lower blood cholesterol.
Objective: The aim of our study was to evaluate the association between low blood cholesterol (<5.16 mmol/L) and cancer at sites that have rarely been evaluated. We placed special emphasis on the potential confounding effect of antioxidant vitamins.
Design: Plasma concentrations of cholesterol and antioxidant vitamins were measured in 1971–1973 in 2974 men working in Basel, Switzerland. In 1990, the vital status of all participants was assessed.
Results: Two hundred ninety of the participants had died from cancer, 87 from lung, 30 from prostate, 28 from stomach, and 22 from colon cancer. Group means for plasma cholesterol concentrations did not differ significantly between survivors and those who died from cancer at any of the studied sites. With plasma cholesterol, vitamins C and E, retinol, carotene, smoking, and age accounted for in a Cox model, an increase in total cancer mortality in lung, prostate, and colon but not in stomach cancer mortality was observed in men >60 y of age with low plasma cholesterol. When data from the first 2 y of follow-up were excluded from the analysis, the relative risk estimates remained practically unchanged with regard to lung cancer but decreased for colon, prostate, and overall cancer.
Conclusions: Increased cancer mortality risks associated with low plasma cholesterol were not explained by the confounding effect of antioxidant vitamins, but were attributed in part to the effect of preexisting cancer.
Key Words: Cancer mortality • low plasma cholesterol • cohort study • men • elderly • antioxidants • vitamins • lung cancer • colon cancer • prostate cancer • stomach cancer • Switzerland
This article has been cited by other articles:
|
|
 |
|
  E. A. Platz, C. Till, P. J. Goodman, H. L. Parnes, W. D. Figg, D. Albanes, M. L. Neuhouser, E. A. Klein, I. M. Thompson Jr., and A. R. Kristal Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 2807 - 2813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Strasak, R. M. Pfeiffer, L. J. Brant, K. Rapp, W. Hilbe, W. Oberaigner, S. Lang, W. Borena, H. Concin, G. Diem, et al. Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up study Ann. Onc., June 1, 2009; 20(6): 1113 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sritara, P. Patoomanunt, M. Woodward, K. Narksawat, S. Tulyadachanon, W. Ratanachaiwong, C. Sritara, F. Barzi, S. Yamwong, and S. Tanomsup Associations Between Serum Lipids and Causes of Mortality in a Cohort of 3499 Urban Thais: The Electricity Generating Authority of Thailand (EGAT) Study Angiology, January 1, 2008; 58(6): 757 - 763. [Abstract] [PDF]
|
|
|
|
 |
|
 V. Khurana, H. R. Bejjanki, G. Caldito, and M. W. Owens Statins Reduce the Risk of Lung Cancer in Humans: A Large Case-Control Study of US Veterans Chest, May 1, 2007; 131(5): 1282 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bowers, D. Albanes, P. Limburg, P. Pietinen, P. R. Taylor, J. Virtamo, and R. Stolzenberg-Solomon A Prospective Study of Anthropometric and Clinical Measurements Associated with Insulin Resistance Syndrome and Colorectal Cancer in Male Smokers Am. J. Epidemiol., October 1, 2006; 164(7): 652 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Panagiotakos, C. Pitsavos, E. Polychronopoulos, C. Chrysohoou, A. Menotti, A. Dontas, and C. Stefanadis Total Cholesterol and Body Mass Index in Relation to 40-Year Cancer Mortality (The Corfu Cohort of the Seven Countries Study) Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1797 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Mainous III, B. J. Wells, R. J. Koopman, C. J. Everett, and J. M. Gill Iron, Lipids, and Risk of Cancer in the Framingham Offspring Cohort Am. J. Epidemiol., June 15, 2005; 161(12): 1115 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Homma, Y. Kondo, M. Kaneko, T. Kitamura, W. T. Nyou, M. Yanagisawa, Y. Yamamoto, and T. Kakizoe Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate Carcinogenesis, June 1, 2004; 25(6): 1011 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. W. Chan, A. M. Oza, and L. L. Siu The Statins as Anticancer Agents Clin. Cancer Res., January 1, 2003; 9(1): 10 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hughes-Fulford, Y. Chen, and R. R. Tjandrawinata Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells Carcinogenesis, May 1, 2001; 22(5): 701 - 707. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
